PATENT CLAIM ANALYSIS

Application Number: 16142421
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["424", "139100"]

Abstract:
The present disclosure relates to antibodies and polynucleotides encoding the same, which may be used to prevent, control, or reduce the activity of the complement pathway. In addition, the disclosure is directed to compositions and methods for diagnosing and treating diseases mediated by or involving complement Factor Bb. Specifically, the disclosure is related to anti-complement Factor Bb antibodies.

Claim (Index 3):
The nucleic acid of  claim 2 , wherein the antibody binds Factor Bb with a K d  of less than about 1 nM.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 97.0
- Lexical Diversity: 1.53488
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14631057', '15790759', '15665030', '15510545', '14626514']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6915705215131863
- 35 USC 102 Novelty (BERT): 0.5522729906351398
- Combined Prediction Score: 0.6776407684253817
- Mean Citation Score: 351.64685
- Max Citation Score: 394.84943
- Similarity Product: 344.80247957370216

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test